366 related articles for article (PubMed ID: 34633442)
1. Gain-of-function variants in GABRD reveal a novel pathway for neurodevelopmental disorders and epilepsy.
Ahring PK; Liao VWY; Gardella E; Johannesen KM; Krey I; Selmer KK; Stadheim BF; Davis H; Peinhardt C; Koko M; Coorg RK; Syrbe S; Bertsche A; Santiago-Sim T; Diemer T; Fenger CD; Platzer K; Eichler EE; Lerche H; Lemke JR; Chebib M; Møller RS
Brain; 2022 May; 145(4):1299-1309. PubMed ID: 34633442
[TBL] [Abstract][Full Text] [Related]
2. Common molecular mechanisms of SLC6A1 variant-mediated neurodevelopmental disorders in astrocytes and neurons.
Mermer F; Poliquin S; Rigsby K; Rastogi A; Shen W; Romero-Morales A; Nwosu G; McGrath P; Demerast S; Aoto J; Bilousova G; Lal D; Gama V; Kang JQ
Brain; 2021 Sep; 144(8):2499-2512. PubMed ID: 34028503
[TBL] [Abstract][Full Text] [Related]
3. Endoplasmic reticulum retention and degradation of a mutation in SLC6A1 associated with epilepsy and autism.
Wang J; Poliquin S; Mermer F; Eissman J; Delpire E; Wang J; Shen W; Cai K; Li BM; Li ZY; Xu D; Nwosu G; Flamm C; Liao WP; Shi YW; Kang JQ
Mol Brain; 2020 May; 13(1):76. PubMed ID: 32398021
[TBL] [Abstract][Full Text] [Related]
4. Haploinsufficiency underlies the neurodevelopmental consequences of SLC6A1 variants.
Silva DB; Trinidad M; Ljungdahl A; Revalde JL; Berguig GY; Wallace W; Patrick CS; Bomba L; Arkin M; Dong S; Estrada K; Hutchinson K; LeBowitz JH; Schlessinger A; Johannesen KM; Møller RS; Giacomini KM; Froelich S; Sanders SJ; Wuster A
Am J Hum Genet; 2024 Jun; 111(6):1222-1238. PubMed ID: 38781976
[TBL] [Abstract][Full Text] [Related]
5. Defining the phenotypic spectrum of SLC6A1 mutations.
Johannesen KM; Gardella E; Linnankivi T; Courage C; de Saint Martin A; Lehesjoki AE; Mignot C; Afenjar A; Lesca G; Abi-Warde MT; Chelly J; Piton A; Merritt JL; Rodan LH; Tan WH; Bird LM; Nespeca M; Gleeson JG; Yoo Y; Choi M; Chae JH; Czapansky-Beilman D; Reichert SC; Pendziwiat M; Verhoeven JS; Schelhaas HJ; Devinsky O; Christensen J; Specchio N; Trivisano M; Weber YG; Nava C; Keren B; Doummar D; Schaefer E; Hopkins S; Dubbs H; Shaw JE; Pisani L; Myers CT; Tang S; Tang S; Pal DK; Millichap JJ; Carvill GL; Helbig KL; Mecarelli O; Striano P; Helbig I; Rubboli G; Mefford HC; Møller RS
Epilepsia; 2018 Feb; 59(2):389-402. PubMed ID: 29315614
[TBL] [Abstract][Full Text] [Related]
6. Neurodevelopmental phenotypes associated with pathogenic variants in
Kahen A; Kavus H; Geltzeiler A; Kentros C; Taylor C; Brooks E; Green Snyder L; Chung W
J Med Genet; 2022 Jun; 59(6):536-543. PubMed ID: 34006619
[TBL] [Abstract][Full Text] [Related]
7. Genetic mosaicism, intrafamilial phenotypic heterogeneity, and molecular defects of a novel missense SLC6A1 mutation associated with epilepsy and ADHD.
Poliquin S; Hughes I; Shen W; Mermer F; Wang J; Mack T; Xu D; Kang JQ
Exp Neurol; 2021 Aug; 342():113723. PubMed ID: 33961861
[TBL] [Abstract][Full Text] [Related]
8. Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications.
Johannesen KM; Liu Y; Koko M; Gjerulfsen CE; Sonnenberg L; Schubert J; Fenger CD; Eltokhi A; Rannap M; Koch NA; Lauxmann S; Krüger J; Kegele J; Canafoglia L; Franceschetti S; Mayer T; Rebstock J; Zacher P; Ruf S; Alber M; Sterbova K; Lassuthová P; Vlckova M; Lemke JR; Platzer K; Krey I; Heine C; Wieczorek D; Kroell-Seger J; Lund C; Klein KM; Au PYB; Rho JM; Ho AW; Masnada S; Veggiotti P; Giordano L; Accorsi P; Hoei-Hansen CE; Striano P; Zara F; Verhelst H; Verhoeven JS; Braakman HMH; van der Zwaag B; Harder AVE; Brilstra E; Pendziwiat M; Lebon S; Vaccarezza M; Le NM; Christensen J; Grønborg S; Scherer SW; Howe J; Fazeli W; Howell KB; Leventer R; Stutterd C; Walsh S; Gerard M; Gerard B; Matricardi S; Bonardi CM; Sartori S; Berger A; Hoffman-Zacharska D; Mastrangelo M; Darra F; Vøllo A; Motazacker MM; Lakeman P; Nizon M; Betzler C; Altuzarra C; Caume R; Roubertie A; Gélisse P; Marini C; Guerrini R; Bilan F; Tibussek D; Koch-Hogrebe M; Perry MS; Ichikawa S; Dadali E; Sharkov A; Mishina I; Abramov M; Kanivets I; Korostelev S; Kutsev S; Wain KE; Eisenhauer N; Wagner M; Savatt JM; Müller-Schlüter K; Bassan H; Borovikov A; Nassogne MC; Destrée A; Schoonjans AS; Meuwissen M; Buzatu M; Jansen A; Scalais E; Srivastava S; Tan WH; Olson HE; Loddenkemper T; Poduri A; Helbig KL; Helbig I; Fitzgerald MP; Goldberg EM; Roser T; Borggraefe I; Brünger T; May P; Lal D; Lederer D; Rubboli G; Heyne HO; Lesca G; Hedrich UBS; Benda J; Gardella E; Lerche H; Møller RS
Brain; 2022 Sep; 145(9):2991-3009. PubMed ID: 34431999
[TBL] [Abstract][Full Text] [Related]
9. A de novo missense variant in GABRA4 alters receptor function in an epileptic and neurodevelopmental phenotype.
Vogel FD; Krenn M; Westphal DS; Graf E; Wagner M; Leiz S; Koniuszewski F; Augé-Stock M; Kramer G; Scholze P; Ernst M
Epilepsia; 2022 Apr; 63(4):e35-e41. PubMed ID: 35152403
[TBL] [Abstract][Full Text] [Related]
10. De Novo Missense Variants in SLC32A1 Cause a Developmental and Epileptic Encephalopathy Due to Impaired GABAergic Neurotransmission.
Platzer K; Sticht H; Bupp C; Ganapathi M; Pereira EM; Le Guyader G; Bilan F; Henderson LB; Lemke JR; Taschenberger H; Brose N; Abou Jamra R; Wojcik SM
Ann Neurol; 2022 Dec; 92(6):958-973. PubMed ID: 36073542
[TBL] [Abstract][Full Text] [Related]
11. Astrocytic GABA transporter 1 deficit in novel SLC6A1 variants mediated epilepsy: Connected from protein destabilization to seizures in mice and humans.
Mermer F; Poliquin S; Zhou S; Wang X; Ding Y; Yin F; Shen W; Wang J; Rigsby K; Xu D; Mack T; Nwosu G; Flamm C; Stein M; Kang JQ
Neurobiol Dis; 2022 Oct; 172():105810. PubMed ID: 35840120
[TBL] [Abstract][Full Text] [Related]
12. Correlations of receptor desensitization of gain-of-function GABRB3 variants with clinical severity.
Lin SXN; Ahring PK; Keramidas A; Liao VWY; Møller RS; Chebib M; Absalom NL
Brain; 2024 Jan; 147(1):224-239. PubMed ID: 37647766
[TBL] [Abstract][Full Text] [Related]
13. SLC6A1 variants identified in epilepsy patients reduce γ-aminobutyric acid transport.
Mattison KA; Butler KM; Inglis GAS; Dayan O; Boussidan H; Bhambhani V; Philbrook B; da Silva C; Alexander JJ; Kanner BI; Escayg A
Epilepsia; 2018 Sep; 59(9):e135-e141. PubMed ID: 30132828
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the GABRB2-Associated Neurodevelopmental Disorders.
El Achkar CM; Harrer M; Smith L; Kelly M; Iqbal S; Maljevic S; Niturad CE; Vissers LELM; Poduri A; Yang E; Lal D; Lerche H; Møller RS; Olson HE;
Ann Neurol; 2021 Mar; 89(3):573-586. PubMed ID: 33325057
[TBL] [Abstract][Full Text] [Related]
15. Delta subunit susceptibility variants E177A and R220H associated with complex epilepsy alter channel gating and surface expression of alpha4beta2delta GABAA receptors.
Feng HJ; Kang JQ; Song L; Dibbens L; Mulley J; Macdonald RL
J Neurosci; 2006 Feb; 26(5):1499-506. PubMed ID: 16452673
[TBL] [Abstract][Full Text] [Related]
16. GABRD encoding a protein for extra- or peri-synaptic GABAA receptors is a susceptibility locus for generalized epilepsies.
Dibbens LM; Feng HJ; Richards MC; Harkin LA; Hodgson BL; Scott D; Jenkins M; Petrou S; Sutherland GR; Scheffer IE; Berkovic SF; Macdonald RL; Mulley JC
Hum Mol Genet; 2004 Jul; 13(13):1315-9. PubMed ID: 15115768
[TBL] [Abstract][Full Text] [Related]
17. Rare GABRA3 variants are associated with epileptic seizures, encephalopathy and dysmorphic features.
Niturad CE; Lev D; Kalscheuer VM; Charzewska A; Schubert J; Lerman-Sagie T; Kroes HY; Oegema R; Traverso M; Specchio N; Lassota M; Chelly J; Bennett-Back O; Carmi N; Koffler-Brill T; Iacomino M; Trivisano M; Capovilla G; Striano P; Nawara M; Rzonca S; Fischer U; Bienek M; Jensen C; Hu H; Thiele H; Altmüller J; Krause R; May P; Becker F; ; Balling R; Biskup S; Haas SA; Nürnberg P; van Gassen KLI; Lerche H; Zara F; Maljevic S; Leshinsky-Silver E
Brain; 2017 Nov; 140(11):2879-2894. PubMed ID: 29053855
[TBL] [Abstract][Full Text] [Related]
18. Molecular and clinical descriptions of patients with GABA
Maillard PY; Baer S; Schaefer É; Desnous B; Villeneuve N; Lépine A; Fabre A; Lacoste C; El Chehadeh S; Piton A; Porter LF; Perriard C; Wardé MA; Spitz MA; Laugel V; Lesca G; Putoux A; Ville D; Mignot C; Héron D; Nabbout R; Barcia G; Rio M; Roubertie A; Meyer P; Paquis-Flucklinger V; Patat O; Lefranc J; Gerard M; ; de Bellescize J; Villard L; De Saint Martin A; Milh M
Epilepsia; 2022 Oct; 63(10):2519-2533. PubMed ID: 35718920
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the GABA Transporter SLC6A1 Cause Epilepsy with Myoclonic-Atonic Seizures.
Carvill GL; McMahon JM; Schneider A; Zemel M; Myers CT; Saykally J; Nguyen J; Robbiano A; Zara F; Specchio N; Mecarelli O; Smith RL; Leventer RJ; Møller RS; Nikanorova M; Dimova P; Jordanova A; Petrou S; ; Helbig I; Striano P; Weckhuysen S; Berkovic SF; Scheffer IE; Mefford HC
Am J Hum Genet; 2015 May; 96(5):808-15. PubMed ID: 25865495
[TBL] [Abstract][Full Text] [Related]
20. De novo variants in GABRA2 and GABRA5 alter receptor function and contribute to early-onset epilepsy.
Butler KM; Moody OA; Schuler E; Coryell J; Alexander JJ; Jenkins A; Escayg A
Brain; 2018 Aug; 141(8):2392-2405. PubMed ID: 29961870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
